USPTO trademark

MOLECULAR CANCER THERAPEUTICS

RegisteredUSPTOWord markClass 16Class 41

"MOLECULAR CANCER THERAPEUTICS" is a word mark owned by American Association of Cancer Research, Inc., filed at the USPTO on April 22, 2022. It is registered and covers classes 16 and 41.

Get this data via the API

Data current as of July 11, 2023Official USPTO record

As filed with the USPTO

Status: Registered; Since July 11, 2023
Filed: April 22, 2022
Registered: July 11, 2023
Expires: Not recorded
Application no.: 97377394
Registration no.: 7104044
Office: USPTO; United States Patent and Trademark Office
Mark type: Word mark; 2 classes

Ownership

Who owns MOLECULAR CANCER THERAPEUTICS

The owner and representative on file with the office.

Owner

American Association of Cancer Research, Inc.

Philadelphia, United States

Representative

Mark A. Steiner, Esq.

Duane Morris LLP

Goods and services

What the mark covers

The products and services MOLECULAR CANCER THERAPEUTICS is filed for, grouped by Nice class.

16Class 16 · Paper Goods and Printed Matter
Publications, namely, printed journals in the field of medicine
41Class 41 · Education and Entertainment
Online publications, namely, journals in the field of medicine

History

What has happened so far

Steps recorded by the USPTO, newest first.

July 11, 2023Notice of registration confirmation emailed
July 11, 2023Registered-principal register
April 25, 2023Official gazette publication confirmation e-mailed
April 25, 2023Published for opposition
April 5, 2023Notification of notice of publication e-mailed
March 22, 2023Approved for pub - principal register
March 21, 2023Teas/email correspondence entered
March 20, 2023Correspondence received in law office
March 20, 2023Teas response to office action received
March 20, 2023Notification of non-final action e-mailed

8 earlier steps on the official record.

FAQ

About MOLECULAR CANCER THERAPEUTICS

Who owns the trademark "MOLECULAR CANCER THERAPEUTICS"?

The USPTO trademark "MOLECULAR CANCER THERAPEUTICS" (application 97377394) is owned by American Association of Cancer Research, Inc.

What is the status of "MOLECULAR CANCER THERAPEUTICS"?

Its status at the USPTO is: registered.

When was "MOLECULAR CANCER THERAPEUTICS" registered?

It was registered on July 11, 2023.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull MOLECULAR CANCER THERAPEUTICS and marks like it into your own product with one request.

GET/v1/trademarks/{id}
The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/events
Every step in the office history
GET/v1/proceedings?trademark_id={id}
Oppositions and cancellations against the mark

Get API key View docs

GET /v1/trademarks/{id}

ID=tm_019d2a77-7cdd-74f6-b102-836f48f0756b
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"

Response

{
  "id": "tm_019d2a77-7cdd-74f6-b102-836f48f0756b",
  "object": "trademark",
  "mark_text": "MOLECULAR CANCER THERAPEUTICS",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "97377394",
  "filing_date": "2022-04-22",
  "nice_classes": [
    16,
    41
  ],
  "owners": [
    {
      "name": "American Association of Cancer Research, Inc.",
      "entity_id": null
    }
  ]
}